ClinicalTrials.gg
RecruitingNCT06812507Updated Jan 16, 2026

Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile

An interventional study of intact umbilical milking and cut umbilical milking in Premature and Placental Transfusion, sponsored by Alexandria University. Recruiting at 1 site in Egypt. Open to participants aged 1 Minute to 2 Minutes, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Alexandria University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
1 Minute to 2 Minutes
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Premature Birth by Alexandria University — 5 open to participants now, 5 under way, none of them phase 3. Premature Birth · Alexandria University.

Planned enrollment
2nd of 10
160 · median 100
Started
2025
with 1 other
No phase
8 of 10
5 open now
Registered
8th of 10
by date

Among the 10 studies in Premature Birth by Alexandria University, this one is the 2nd largest by planned enrollment, is one of 2 that started in 2025, is one of 8 with no phase, and was the 8th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

5 of the 10 studies in Premature Birth by Alexandria University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 1 Minute to 2 Minutes · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Premature Birth by Alexandria University, or all of them as a file.
02

Study summary

The objective of this study is to evaluate the general course and prognosis associated with different methods of placental transfusion (Intact umbilical cord milking, cut- umbilical cord milking and delayed cord clamping) in premature neonates over the first days of life

03

Conditions studied

  • Premature
  • Placental Transfusion
04

Who can participate

Ages eligible
1 Minute to 2 Minutes
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

  • Inclusion Criteria:

    1. Premature neonates ≤ 32 weeks gestational age regardless birth weight
    2. patients should be admitted to neonatal intensive care unit in the first day of life of life

Exclusion criteria:

  • Exclusion Criteria:

Patient with any of the following will be excluded:

  1. Major congenital anomalies (complex cyanotic heart disease, major central nervous system anomalies).
  2. Evidence of head trauma causing major intracranial hemorrhage.
  3. placental abnormalities like : abruptions, placenta previa or retroplacental hematoma.
  4. Cord accident, or avulsion at the time of delivery.
  5. Refusal to perform the intervention by the obstetrician
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    The procedure of intact umbilical cord milking (I-UCM)

    Umbilical cord milking will be performed by holding the newborn at or ∼20 cm below the level of the placenta. The cord will be pinched between 2 fingers as close to the placenta as possible and milked toward the infant over a 2-second duration. The cord will then be released and allowed to refill with blood for a brief 1- to 2-second pause between each milking motion. This will be repeated for 2-4 times. After completion, the cord will be clamped, and the neonate will be handed to the resuscitation team.

    Procedure: intact umbilical milking

  • Experimental
    The procedure of Cut-umbilical cord milking(C-UCM):

    Another technique, used more often in Asia, involves clamping and cutting a long segment of the umbilical cord immediately at birth and passing the baby and the long cord to the pediatric provider, called C-UCM untwists the cord and milks the entire contents into the baby. Milking the cord 2-3 times before clamping may produce a similar placental transfusion as C-UCM

    Procedure: cut umbilical milking

  • Experimental
    The procedure of Delayed Cord Clamping (DCC):

    Infants placed on the maternal abdomen or at the introitus below the level of placenta and waiting at least 30- to 60-second before clamping the cord.

    Procedure: Delayed cord clamping

  • No intervention
    Control group:

    patients will not receive any of the methods of placental transfusions

Interventions

  • Procedureintact umbilical milking

    Umbilical cord milking will be performed by holding the newborn at or ∼20 cm below the level of the placenta. The cord will be pinched between 2 fingers as close to the placenta as possible and milked toward the infant over a 2-second duration. The cord will then be released and allowed to refill with blood for a brief 1- to 2-second pause between each milking motion. This will be repeated for 2-4 times. After completion, the cord will be clamped, and the neonate will be handed to the resuscitation team.

  • Procedurecut umbilical milking

    Another technique, used more often in Asia, involves clamping and cutting a long segment of the umbilical cord immediately at birth and passing the baby and the long cord to the pediatric provider, called C-UCM untwists the cord and milks the entire contents into the baby. Milking the cord 2-3 times before clamping may produce a similar placental transfusion as C-UCM

  • ProcedureDelayed cord clamping

    Infants placed on the maternal abdomen or at the introitus below the level of placenta and waiting at least 30- to 60-second before clamping the cord.

06

What researchers measure

Primary outcomes

  1. Hemoglobin level

    hemoglobin level will be measured in gram/dl

    Time frame: on admission (In first day after birth),as well as, at end of first , second and third weeks of lives

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data will be available upon reasonable request

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Mar 2026, 12 months after the start.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 6, 2025
StartActual
Mar 10, 2025
Primary completionEst.
Mar 28, 2026
CompletionEst.
Apr 28, 2026
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06812507
Responsible party
Marwa Mohamed Farag (Assistant professor of Pediatrics, Alexandria University) — Principal investigator
First posted
Feb 6, 2025
Start date
Mar 10, 2025
Primary completion
Mar 28, 2026 (estimated)
Completion
Apr 28, 2026 (estimated)
Last update
Jan 16, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion